Using ROC-curves, both for the separate primary tumor locations and for the entire cohort and with regard to TTR as well as OS, an optimal cut-off at 3 (IFITM1 low < 3, IFITM1 high 3–12) was identified and subsequently used for both TTR and OS, irrespectively of tumor location. Here, IFITM1 is linked to neoplasm.